在稀缺的单臂临床试验中,合成数据作为外部控制臂
Severin Elvatun1, Daan Knoors1, Simon Brant2
1Cancer Registry of Norway, Norwegian Institute of Public health, Ullernchausseen 64, 0379 Oslo, Norway.
PLOS digital health
|January 23, 2025
概括
合成数据可以取代药物开发中的外部控制臂的健康登记册数据. 这种方法保持了研究成果,同时提高了患者的隐私和加快研究.
科学领域:
- 医疗信息学 医疗信息学
- 数据科学数据科学数据科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 单臂药物开发研究往往缺乏比较器.
- 卫生登记册数据提供了一个替代方案,但存在访问障碍.
- 临床试验数据很容易被重新识别,因为样本大小小和高卡迪纳利特的特征.
研究的目的:
- 评估合成数据作为保护隐私的代理实证外部控制臂数据.
- 评估合成数据在药物开发中的实用性和隐私风险.
- 引入可逆数据泛化程序,以增强合成数据生成.
主要方法:
- 提出并应用了一种可逆数据概括程序.
- 测试了最先进的合成数据生成器.
- 综合数据实用性和隐私指标使用挪威健康登记数据进行了评估.
主要成果:
- 数据通用化改善了小型,高卡迪纳利度数据集的实用性和隐私.
- 发电机可以产生高效的合成数据,而不会损害经验数据的保密性.
- 合成外部控制臂证明了作为观察数据的替代品的可行性.
结论:
- 合成数据,特别是数据泛化,可以有效地作为药物开发中的外部控制武器.
- 这种方法增强了患者的隐私,并有可能加速药物批准过程.
- 合成数据为制药研究中的比较研究提供了安全有效的替代方案.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.4K
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.6K
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
115
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
115
01:12Hazard Ratio
81
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
81